Citadel Advisors’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $43.2M | Buy |
|
|||||
|
2025
Q2 | $8.99M | Sell |
|
|||||
|
2025
Q1 | $31.5M | Buy |
|
|||||
|
2024
Q4 | $67.4M | Sell |
|
|||||
|
2024
Q3 | $106M | Sell |
|
|||||
|
2024
Q2 | $152M | Buy |
|
|||||
|
2024
Q1 | $121M | Buy |
|
|||||
|
2023
Q4 | $40.6M | Buy |
|
|||||
|
2023
Q3 | $27.3M | Buy |
|
|||||
|
2023
Q2 | $30.4M | Sell |
|
|||||
|
2023
Q1 | $34.9M | Buy |
|
|||||
|
2022
Q4 | $33.7M | Sell |
|
|||||
|
2022
Q3 | $37.1M | Sell |
|
|||||
|
2022
Q2 | $20.1M | Sell |
|
|||||
|
2022
Q1 | $28.6M | Buy |
|
|||||
|
2021
Q4 | $34.1M | Sell |
|
|||||
|
2021
Q3 | $46.7M | Sell |
|
|||||
|
2021
Q2 | $61.4M | Sell |
|
|||||
|
2021
Q1 | $48.1M | Sell |
|
|||||
|
2020
Q4 | $66.5M | Buy |
|
|||||
|
2020
Q3 | $59.9M | Buy |
|